Please login to the form below

Not currently logged in

Novo Nordisk acquires two US biopharma companies

Novo Nordisk headquarters

Strikes deals with Calibrium LLC and MB2

Amgen and Novartis collaborate on Alzheimer’s research

Amgen flagWill work on the development and commercialisation of BACE inhibitors

Novartis bags EU approvals for three ex-GSK drugs

Novartis buildingRevolade, Tafinlar and Mekinist all receive regulatory approval

Industry files complaint against France's off-label law

Roche Avastin bevacizumabProtests against promotion of Roche's Avastin as cheap eye medication

Alnylam predicts big things for its PCSK9 inhibitor ALN-PCS

AlnylamGene silencing specialist says its early-stage candidate has blockbuster potential

Bayer moves heart failure candidate finerenone into phase III

Bayer symbolFollows positive phase IIb data presented at the European Society of Cardiology (ESC) meeting

GCI Health expands into medical education

GCI Health Cally Clarkson medical educationComms agency appoints Cally Clarkson to lead its new offering in the area

Roche wins first approval for skin cancer drug Cotellic

Switzerland flagSwiss regulators give the Exelixis-discovered treatment the green light

NICE recommends Daiichi Sankyo's Lixiana for DVT and PE

Daiichi Sankyo logoInstitute's final guidance concludes the novel oral anticoagulant is cost effective

Oncology directions

With increasingly expensive cancer drugs, what price should be paid for innovation?

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Lucid Group Limited

Lucid are specialists committed to delivering excellent medical education that changes clinical practice. Our confidence in understanding therapy areas, together...

Latest intelligence

Competition from within
Published in eyeforpharma July 29 by Rachel Howard...
Infographic: RA Perceptions
HCPs predict the future of the biologics market...
From chaos to calm: how to make sense of social media
What do you know about chaos theory?...